Literature DB >> 27501413

miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.

Hong-Ling Yan1, Li Li2, Shu-Juan Li1, Hai-Sheng Zhang1, Wei Xu3.   

Abstract

The aim of this study is to determine the expression and roles of miR-346 in nasopharyngeal carcinoma (NPC). We showed that miR-346 was upregulated in NPC tissues compared with adjacent non-tumorous nasopharyngeal tissues. Inhibition of miR-346 significantly attenuated the migration and invasion of NPC cells. Luciferase reporter assay showed that miR-346 targeted the 3'-untranslated region (3'-UTR) of breast cancer metastasis suppressor 1 (BRMS1). Overexpression of miR-346 suppressed the endogenous expression of BRMS1 in NPC cells. There was a significant negative correlation between miR-346 and BRMS1 protein expression in NPC tissues (r = -0.372, P = 0.008). Rescue experiments demonstrated that overexpression of BRMS1 lacking the 3'-UTR impaired the invasiveness of NPC cells transfected with miR-346 mimic. Taken together, miR-346 shows the ability to promote the migration and invasion of nasopharyngeal cancer cells via targeting BRMS1 and represents a potential therapeutic target for NPC.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  invasion; microRNA; migration; nasopharyngeal carcinoma; target gene

Mesh:

Substances:

Year:  2016        PMID: 27501413     DOI: 10.1002/jbt.21827

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  14 in total

1.  MicroRNA-423 enhances the invasiveness of hepatocellular carcinoma via regulation of BRMS1.

Authors:  Xiangjun Sun; Mingchun Wang; Haiyan Liu; Jian Wang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  MicroRNA-346 regulates neural stem cell proliferation and differentiation by targeting KLF4.

Authors:  Xingyu Miao; Xiaoying Wu; Wei Shi
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  miRNA-346 promotes proliferation, migration and invasion in liver cancer.

Authors:  Qiang Yu; Xia Yang; Weidong Duan; Chonghui Li; Ying Luo; Shichun Lu
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

4.  LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613.

Authors:  Qiying Yao; Li Zhang; Yuchuan Wang; Junli Liu; Liu Yang; Yingjie Wang
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

5.  MicroRNA-92b inhibits epithelial-mesenchymal transition-induced migration and invasion by targeting Smad3 in nasopharyngeal cancer.

Authors:  Chong Zhao; Feipeng Zhao; Huajun Feng; Shengen Xu; Gang Qin
Journal:  Oncotarget       Date:  2017-09-27

6.  miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1.

Authors:  Zhihui Wang; Zhiquan Zhu; Zhong Lin; Youli Luo; Zibin Liang; Caibin Zhang; Jianxu Chen; Peijian Peng
Journal:  Cancer Cell Int       Date:  2019-04-30       Impact factor: 5.722

7.  Five serum microRNAs for detection and predicting of ovarian cancer.

Authors:  Weiwei Wang; Li-Rong Wu; Chunyu Li; Xin Zhou; Ping Liu; Xuemei Jia; Yan Chen; Wei Zhu
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-04-06

8.  miR-346 Inhibited Apoptosis Against Myocardial Ischemia-Reperfusion Injury via Targeting Bax in Rats.

Authors:  Xiangwei Lv; Pan Lu; Yisen Hu; Tongtong Xu
Journal:  Drug Des Devel Ther       Date:  2020-02-27       Impact factor: 4.162

9.  Circular RNA circLDB2 functions as a competing endogenous RNA to suppress development and promote cisplatin sensitivity in non-squamous non-small cell lung cancer.

Authors:  Yuanyuan Wang; Luguang Li; Weiyu Zhang; Guojun Zhang
Journal:  Thorac Cancer       Date:  2021-06-06       Impact factor: 3.500

10.  MicroRNA-3200-5p Promotes Osteosarcoma Cell Invasion via Suppression of BRMS1.

Authors:  Gen Li; Li Li; Qi Sun; Jiezhou Wu; Wei Ge; Guanghua Lu; Ming Cai
Journal:  Mol Cells       Date:  2018-06-11       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.